SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001698530-22-000031
Filing Date
2022-05-16
Accepted
2022-05-16 16:13:54
Documents
14
Period of Report
2022-05-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xcur-20220516.htm   iXBRL 8-K 33697
2 EX-99.1 a8kq12022exhibit991.htm EX-99.1 89224
6 exicureimage1a10.gif GRAPHIC 2794
  Complete submission text file 0001698530-22-000031.txt   277863

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xcur-20220516.xsd EX-101.SCH 1905
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xcur-20220516_lab.xml EX-101.LAB 24831
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xcur-20220516_pre.xml EX-101.PRE 13045
8 EXTRACTED XBRL INSTANCE DOCUMENT xcur-20220516_htm.xml XML 10984
Mailing Address 2430 N. HALSTED ST. CHICAGO IL 60614
Business Address 2430 N. HALSTED ST. CHICAGO IL 60614 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

IRS No.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39011 | Film No.: 22929159
SIC: 2834 Pharmaceutical Preparations